28.08.2014 Views

Thailand - Stop TB Partnership

Thailand - Stop TB Partnership

Thailand - Stop TB Partnership

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Executive Summary<br />

Tuberculosis incidence in <strong>Thailand</strong>, which fell by 50 percent from 1985 to 1991, rose again<br />

in the 1990s with the emergence of the HIV/AIDS epidemic. Today <strong>Thailand</strong> has an incidence<br />

rate of 142 cases per 100,000 people, and is 18th on the World Health Organization’s<br />

list of high-burden countries.<br />

<strong>Thailand</strong>, through the National Tuberculosis Programme (NTP), has committed<br />

itself to implementing the internationally recommended DOTS strategy, which emphasizes<br />

directly observed treatment, and achieving the international <strong>TB</strong> control targets of 70 percent<br />

detection rate and 85 percent treatment success rate. The government reports considerable<br />

progress in meeting these goals: 100 percent DOTS coverage by 2002; and, more recently,<br />

a 71 percent detection rate and 73 percent treatment success rate.<br />

Some Thai experts, however, question the reliability of these statistics. DOTS coverage,<br />

detection, and treatment vary widely from place to place in <strong>Thailand</strong>. The 73 percent<br />

treatment success rate masks rates as low as 25 percent among some vulnerable groups such<br />

as migrant workers and injection drug users. In addition, since detection and treatment rely<br />

only on one form of diagnosis (active, sputum smear-positive cases), the overall treatment<br />

success rate for those with active <strong>TB</strong> may be considerably lower.<br />

Budget reductions resulting from health care reforms have had a dramatic impact<br />

on the NTP’s capacity to fight <strong>TB</strong>, particularly with regard to monitoring and evaluation,<br />

staffing, training, and public awareness-raising efforts. The integration of <strong>TB</strong> and HIV/AIDS<br />

departments at the central level appears to have resulted in <strong>TB</strong> being overshadowed by the<br />

more powerful AIDS program, rather than becoming its equal partner.<br />

Civil society actors, such as recovered <strong>TB</strong> patients and community health activists,<br />

do not play an active role in <strong>TB</strong> policy development. The NTP’s media outreach efforts have<br />

been minimal, and few nongovernmental organizations (NGOs) have initiated <strong>TB</strong> advocacy<br />

and treatment education efforts.<br />

In the absence of easily accessible, accurate information about <strong>TB</strong> and <strong>TB</strong>/HIV,<br />

public awareness of the basic facts about <strong>TB</strong>—and the serious threat <strong>TB</strong> poses to public<br />

health—is low. <strong>TB</strong> is widely viewed as a curable but rare disease. Stigmatization of people<br />

living with <strong>TB</strong> and <strong>TB</strong>/HIV, and of women in particular, is an issue of concern.<br />

Increased NTP funding and support for advocacy, communication, and social<br />

mobilization activities could play a crucial role in addressing many of these concerns. Key<br />

activities could include the following:<br />

• Establish and staff a specialized department within the NTP to oversee the development<br />

and implementation, in partnership with community representatives, of a<br />

plan to increase public awareness about <strong>TB</strong> and <strong>TB</strong>/HIV.<br />

36<br />

<strong>TB</strong> POLICY IN THAILAND

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!